File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Obstructive sleep apnea and its management in patients with atrial fibrillation: An International Collaboration of Sleep Apnea Cardiovascular Trialists (INCOSACT) global survey of practicing cardiologists

TitleObstructive sleep apnea and its management in patients with atrial fibrillation: An International Collaboration of Sleep Apnea Cardiovascular Trialists (INCOSACT) global survey of practicing cardiologists
Authors
KeywordsAtrial fibrillation
Clinical equipoise
International
Sleep apnea
Survey
Issue Date19-Jul-2023
PublisherElsevier
Citation
IJC Heart & Vasculature, 2022, v. 42 How to Cite?
Abstract

Background: Among international cardiologists it is unclear whether equipoise exists regarding the benefit of diagnosing and managing obstructive sleep apnea (OSA) to improve atrial fibrillation (AF) outcomes and whether clinical practice and equipoise are linked. Methods: Between January 2019 and June 2020 we distributed a web-based 12-question survey regarding OSA and AF management to practicing cardiologists in 16 countries. Results: The United States, Japan, Sweden, and Turkey accounted for two-thirds of responses. 863 cardiologists responded; half were general cardiologists, a quarter electrophysiologists. Responses regarding treating OSA with CPAP to improve AF endpoints were mixed. 33% of respondents referred AF patients for OSA screening. OSA was diagnosed in 48% of referred patients and continuous positive airway pressure (CPAP) was prescribed for 59% of them. Nearly 70% of respondents believed randomized controlled trials (RCTs) of OSA treatment in AF patients were necessary and indicated willingness to contribute to such trials. Conclusions: There was no clinical equipoise among surveyed cardiologists; a majority expressed certainty that combined OSA and AF treatment is superior to AF treatment alone for improving AF outcomes. However, a minority of surveyed cardiologists referred AF patients for OSA testing, and while half of screened AF patients had OSA, CPAP was prescribed in little more than half of them, reflecting the view that better clinical trial evidence is needed to support this practice. Our results underscore the need for larger, multi-national prospective studies of OSA treatment and AF outcomes to inform more uniform society guideline recommendations.


Persistent Identifierhttp://hdl.handle.net/10722/338459
ISSN
2023 Impact Factor: 2.5
2023 SCImago Journal Rankings: 0.753
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorFaulx, MD-
dc.contributor.authorMehra, R-
dc.contributor.authorReis, Geovanini G-
dc.contributor.authorAndo, Shin-ichi-
dc.contributor.authorArzt, M-
dc.contributor.authorDrager, L-
dc.contributor.authorFu, M-
dc.contributor.authorHoyos, C-
dc.contributor.authorHai, J-
dc.contributor.authorHwang, JJ-
dc.contributor.authorKaraoguz, R-
dc.contributor.authorKimoff, J-
dc.contributor.authorLee, PL-
dc.contributor.authorMediano, O-
dc.contributor.authorPatel, SR-
dc.contributor.authorPeker, Y-
dc.contributor.authorLouis, Pepin J-
dc.contributor.authorSanchez-de-la-Torre, M-
dc.contributor.authorSériès, F-
dc.contributor.authorStadler, S-
dc.contributor.authorStrollo, P-
dc.contributor.authorTahrani, AA-
dc.contributor.authorThunström, E-
dc.contributor.authorYamauchi, M-
dc.contributor.authorRedline, S-
dc.contributor.authorPhillips, CL-
dc.date.accessioned2024-03-11T10:29:03Z-
dc.date.available2024-03-11T10:29:03Z-
dc.date.issued2023-07-19-
dc.identifier.citationIJC Heart & Vasculature, 2022, v. 42-
dc.identifier.issn2352-9067-
dc.identifier.urihttp://hdl.handle.net/10722/338459-
dc.description.abstract<p>Background: Among international cardiologists it is unclear whether equipoise exists regarding the benefit of diagnosing and managing obstructive sleep apnea (OSA) to improve atrial fibrillation (AF) outcomes and whether clinical practice and equipoise are linked. Methods: Between January 2019 and June 2020 we distributed a web-based 12-question survey regarding OSA and AF management to practicing cardiologists in 16 countries. Results: The United States, Japan, Sweden, and Turkey accounted for two-thirds of responses. 863 cardiologists responded; half were general cardiologists, a quarter electrophysiologists. Responses regarding treating OSA with CPAP to improve AF endpoints were mixed. 33% of respondents referred AF patients for OSA screening. OSA was diagnosed in 48% of referred patients and continuous positive airway pressure (CPAP) was prescribed for 59% of them. Nearly 70% of respondents believed randomized controlled trials (RCTs) of OSA treatment in AF patients were necessary and indicated willingness to contribute to such trials. Conclusions: There was no clinical equipoise among surveyed cardiologists; a majority expressed certainty that combined OSA and AF treatment is superior to AF treatment alone for improving AF outcomes. However, a minority of surveyed cardiologists referred AF patients for OSA testing, and while half of screened AF patients had OSA, CPAP was prescribed in little more than half of them, reflecting the view that better clinical trial evidence is needed to support this practice. Our results underscore the need for larger, multi-national prospective studies of OSA treatment and AF outcomes to inform more uniform society guideline recommendations.</p>-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofIJC Heart & Vasculature-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectAtrial fibrillation-
dc.subjectClinical equipoise-
dc.subjectInternational-
dc.subjectSleep apnea-
dc.subjectSurvey-
dc.titleObstructive sleep apnea and its management in patients with atrial fibrillation: An International Collaboration of Sleep Apnea Cardiovascular Trialists (INCOSACT) global survey of practicing cardiologists-
dc.typeArticle-
dc.identifier.doi10.1016/j.ijcha.2022.101085-
dc.identifier.scopuseid_2-s2.0-85134639232-
dc.identifier.volume42-
dc.identifier.isiWOS:000860734300002-
dc.identifier.issnl2352-9067-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats